-
In the next 3-5 years, China's innovative pharmaceutical companies will usher in a big test! How to deal with it?
Time of Update: 2022-09-06
" The industry said that with the increasing cost of innovative research and development and the low return on investment in the single market, the layout of pharmaceutical companies in the international market is a new way out, which is also conducive to enhancing the competitiveness of innovative enterprises.
-
The medical equipment track ushered in a wave of listings, and many companies embarked on the road to IPO
Time of Update: 2022-09-06
According to public information, Mingfeng Medical focuses on high-end medical imaging equipment, and its main products and services include the sales and after-sales maintenance services of large-scale medical imaging equipment such as CT and PET/CT, of which the company has listed 18 CT products and 3 PET/CT products.
-
The rare disease drug market may approach 40 billion!
Time of Update: 2022-09-06
com, 53 rare disease drugs have been included in the national medical insurance, including human immunoglobulin, rosuvastatin, ezetimibe and other large varieties with terminal sales of over 1 billion yuan in China's public medical institutions in 2021 .
-
FDA approves upgraded version of Moderna, Pfizer vaccines for certain populations
Time of Update: 2022-09-06
S. Food and Drug Administration on August 31 revised the emergency use authorization for Moderna and Pfizer’s new crown vaccines, approving certain age groups to receive upgraded versions of these two vaccines as booster shots to provide for the Omicron variant.
-
"Countdown" to the reform of medical insurance accounts in many places!
Time of Update: 2022-09-06
In fact, since the State Council issued the "Guiding Opinions on Establishing and Improving the Outpatient Mutual Assistance Mechanism of Employee Basic Medical Insurance" (hereinafter referred to as the "Guiding Opinions") in April last year, the exploration of the reform of the employee medical insurance personal account system in various provinces and cities across the country is being carried out one after another.
-
Tigermed, Kain Technology, Beida Pharmaceutical and other pharmaceutical companies have been rated as "buy" by institutions
Time of Update: 2022-09-06
The reasons for the rating mainly include: 1) Focus on innovative drugs, and the access of Kailiwei is progressing smoothly; 2) R&D investment continues to increase, accelerating the layout of hepatitis B functional cure pipeline; 3) Mature products JinShuxi and Kaiyin Yisheng maintain a high status.
-
The medical industry ushered in a major reshuffle and will gradually move from "barbaric growth" to standardized development
Time of Update: 2022-09-06
Recently, the Yunting Branch of the Jiangyin Municipal Supervision Bureau in Jiangsu Province has carried out in-depth special management of medical chaos and severely cracked down on violations of laws and regulations in the medical industry.
-
Mindray Medical was surveyed by 476 institutions in one week! Last week, institutions gathered to investigate pharmaceutical stocks
Time of Update: 2022-09-06
In the institutional survey, Kaili Medical said that in the first half of 2022, the company's various business developments are in line with the planning formulated at the beginning of the year, the ultrasound business grows steadily, the endoscopic business maintains a high growth rate, and the overall company's revenue increases significantly, and the net profit performance is better.
-
The innovation and development of the pharmaceutical equipment industry has become a trend Head enterprises have opened a large-scale expansion of talents
Time of Update: 2022-09-06
In recent years, with the rapid development of the pharmaceutical industry and the acceleration of innovation and upgrading, as well as the continuous breakthrough of emerging biotechnology in China, the promotion of emerging industries such as biomedicine and health industry, the market demand for high-end pharmaceutical equipment has been expanding.
-
Medical insurance, collection, national standard implementation... Opportunities and challenges coexist in the Traditional Chinese medicine formula granule industry
Time of Update: 2022-09-06
At the end of August, the Anhui Provincial Medical Insurance Bureau and other departments jointly issued a document to clearly include 343 Chinese medicine formula granules such as Poria (196 Chinese standards and 147 provincial standards) into the scope of medical insurance payment in Anhui Province.
-
Notice of Issuing the Measures for the Administration of Network Security of Medical and Health Institutions
Time of Update: 2022-09-06
(5) In response to the hidden problems found in the rating evaluation, each medical and health institution shall formulate a network security rectification plan in accordance with the requirements of laws, regulations, policies and standards in accordance with external threats and risks, carry out targeted rectification, and eliminate hidden risks in a timely manner , strengthen management and technical shortcomings, and improve security protection capabilities .
-
Never allow oral implantation to become a "cash cow" related charges are planned to be specially treated
Time of Update: 2022-09-06
Centralized procurement and procurement squeeze out water and strengthen price abnormality warning Recently, the National Medical Security Bureau has solicited opinions from the public regarding the special treatment of dental implant medical service charges and consumable prices.
-
The keel resources are exhausted, and the cost of raw materials for Jianmin Pharmaceuticals has greatly increased!
Time of Update: 2022-09-06
In this issue, Tiandi Yuntu Pharmaceutical Industry Big Data Platform analyzes the cost pressure of traditional Chinese medicine raw materials faced by enterprises from the perspective of the raw materials involved in its core product, Longmu Zhuanggu Granules .
-
Heavy, the National Medical Insurance Bureau issued a document to support the pharmacy service fee!
Time of Update: 2022-09-06
Medicine Procurement Health On August 24, the National Medical Security Administration made an official reply to the proposal No. 7308 of the Fifth Session of the 13th National People's Congress - "Proposal on Implementing Pharmacy Service Fees as Soon as Possible to Give Full Play to the Power of Pharmacists" .
-
The domestic antibacterial drug market has entered the market again, and it is predicted that the next 8 years may show a trend of first rising and then falling
Time of Update: 2022-09-06
【Pharmaceutical Network Market Analysis】 In the field of steady growth of antibacterial drugs, the author learned that a pharmaceutical company has recently ushered in.
【Pharmaceutical Network Market Analysis】 In the field of steady growth of antibacterial drugs, the author learned that a pharmaceutical company has recently ushered in.
-
Targeted use from September 1, how to use Beijing medical insurance personal account funds?
Time of Update: 2022-09-06
However, you can use your social security card to use your personal account (including mutual aid account) for payment, and the shortfall will be made up by the insured in cash .
-
Miracle of Mind: Stroke Sequela BATA Conditioning!
Time of Update: 2022-09-06
Patients need long-term medication, even if the most advanced treatment methods are currently available, more than 50% of them are still unable to take care of themselves, and 30% are at risk of recurrence!The sequelae of stroke mainly include: half-body failure, limb numbness, sensory impairment, language impairment, memory loss, crooked mouth and eyes, ataxia, dizziness and headache.
-
13 departments have introduced policies and measures to support the elderly care service industry
Time of Update: 2022-09-06
The reporter learned on the 30th that 13 departments including the National Development and Reform Commission recently issued a notice on "Several Policies and Measures for Relief and Support of the Pension and Nursing Service Industry", which clarified rent reduction and exemption, tax reduction and exemption, social insurance support, financial support, epidemic prevention support and Other support and other 26 relief and support measures .
-
Gene drugs will become another pillar in the field of medicine Related industrial chains are expected to benefit
Time of Update: 2022-09-06
Gene drugs will become another pillar of the pharmaceutical field Related industry chain is expected to benefit (image source: pharmaceutical network) Data show that in recent years, the global gene drug market size has continued to grow, since 2021 will maintain a growth rate of more than 65%, is expected to exceed 30 billion US dollars by 2025.
-
Kexing Pharmaceutical released its semi-annual report "Innovative R&D + Product Introduction" with remarkable progress
Time of Update: 2022-09-06
On the evening of August 29, Kexing Pharmaceutical (688136. SH) released the 2022 semi-annual report, during the reporting period, the company achieved a total operating income of 629 million yuan, a
